Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Recruiting2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05026138Recruiting
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Human Papillomavirus
PrincipalinvestigatorStart date: 2021-11-17
NCT03519464Phase 2Active Not Recruiting
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia
Idiopathic CD4 T Cell Lymphocytopenia
PrincipalinvestigatorStart date: 2019-02-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute of Allergy and Infectious Diseases (NIAID)

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05600920Phase 1/2PrincipalInvestigator

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

Idiopathic CD4 Lymphopenia
Recruiting
NCT05026138PrincipalInvestigator

Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)

Human Papillomavirus
Recruiting
NCT03519464Phase 2PrincipalInvestigator

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Idiopathic CD4 T Cell Lymphocytopenia
Active Not Recruiting

All 3 trials loaded